Acupuncture needles meet immunotherapy: a new hope for tough lung cancers?

NCT ID NCT07239661

Recruiting now Disease control Sponsor: Kong Fanming Source: ClinicalTrials.gov ↗

First seen Nov 20, 2025 · Last updated Apr 29, 2026 · Updated 20 times

Summary

This study is for people with advanced non-small cell lung cancer who are too weak for strong chemotherapy (ECOG 2). It tests whether adding electroacupuncture (a type of acupuncture with mild electric pulses) to standard immunotherapy (PD-1 inhibitors) can help them live longer without their cancer getting worse. About 120 participants will be randomly assigned to get either real or fake acupuncture alongside their immunotherapy. The study also looks at quality of life and tries to find biological markers that predict who benefits most.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
RECRUITING

Tianjin, Tianjin Municipality, 300193, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ECOG PS 2 POINTS ELECTROACUPUNCTURE NON SMALL CELL LUNG CANCER PD-1 INHIBITORS PD-1 INHIBITORS